logo

For the Inventor, By the Inventor

Tochigi, Japan

Naonobu Yoshizuka

This inventor holds 4 USPTO granted patents. Top assignee: Kao Corporation. Active years: 1986-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naonobu Yoshizuka. Retrieved from https://idiyas.com/inventor/naonobu-yoshizuka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Utsunomiya, JP (1986)
  • Funabashi, JP (1991)
  • Tochigi, JP (1992)

Company Filing History:

goldMedal4 out of 3,678 
 
Kao Corporation
 patents

Years Active: 1986-1992

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5126434 - Monoclonal antibody specific for a human macrophage chemotactic factor (1992-06-30),
2. 5097013 - Novel peptides possessing a macrophage chemotactic activity (1992-03-17),
3. 5053229 - Cosmetic compositions (1991-10-01),
4. 4569931 - Sebum secretion accelerator (1986-02-11),

Title: Naonobu Yoshizuka: Innovator in Monoclonal Antibody Research

Introduction

Naonobu Yoshizuka is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Yoshizuka's work has the potential to impact medical research and therapeutic applications.

Latest Patents

Yoshizuka's latest patents include a monoclonal antibody specific for a human macrophage chemotactic factor. This invention relates to a monoclonal antibody that specifically binds to a peptide with a defined amino acid sequence. Additionally, he has developed novel peptides possessing macrophage chemotactic activity, which are physiologically active and have specific amino acid sequences that enhance macrophage chemotaxis.

Career Highlights

Yoshizuka is currently associated with Kao Corporation, where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in therapeutic settings, particularly in immune response modulation.

Collaborations

Yoshizuka has collaborated with notable colleagues, including Toshiaki Osawa and Genji Imokawa. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Naonobu Yoshizuka is a key figure in the field of monoclonal antibody research, with a focus on macrophage chemotactic factors. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…